Moore Capital Management’s Celgene Corp CELG Stock Holding History

Moore Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-80,000	Closed	-$8.65M	–	422
2015 Q3	$8.65M	Buy	80,000 +30,000	+60%	+$3.72M	0.4%	71
2015 Q2	$5.79M	Buy	+50,000	New	+$5.72M	0.12%	165
2014 Q4	–	Sell	-55,000	Closed	-$5.21M	–	484
2014 Q3	$5.21M	Buy	+55,000	New	+$4.96M	0.12%	199
2014 Q2	–	Sell	-85,228	Closed	-$5.95M	–	656
2014 Q1	$5.95M	Buy	85,228 +75,228	+752%	+$5.96M	0.12%	162
2013 Q4	$845K	Sell	10,000 -30,000	-75%	-$2.37M	0.01%	315
2013 Q3	$3.08M	Buy	+40,000	New	+$2.8M	0.07%	204

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Moore Capital Management's CELG Position: Q4 2015 in Review

Moore Capital Management sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 80,000 shares — an estimated $8.65M sold.

Moore Capital Management first reported a position in CELG in Q3 2013 and held it in 6 quarters. The position peaked at $8.65M in Q3 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

Moore Capital Management reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
Moore Capital Management sold 80,000 Celgene Corp shares in Q4 2015, an estimated $8.65M.
Moore Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 6 quarters.
Moore Capital Management's Celgene Corp position peaked at $8.65M in Q3 2015.
1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on Moore Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.